Generic entry, price competition, and market segmentation in the prescription drug market

Generic entry, price competition, and market segmentation in the prescription drug market

This paper studies the effects of generic entry on post-patent price competition for 18 prescription drugs recently exposed to competition. An independent, validating test of the “generic competition paradox” is conducted using a newly created data set. Each generic entrant is associated with an average 1% increase in the branded price. The one-way error component model accounts for intermolecu...

[Policies encouraging price competition in the generic drug market: Lessons from the European experience].

OBJECTIVES To describe alternative policies aimed at encouraging price competition in generic drug markets in countries with strict price regulation, and to present some case studies drawn from the European experience. METHODS Systematic literature review of articles and technical reports published after 1999. RESULTS The shortcomings in consumer price competition observed in some European ...

Market Structure and Price Adjustment in the Iranian Tea Market

Investigating the Competition Status and the Impact of Market Power on Electricity Price: Case of Iran's Wholesale Electricity Market

Policy makers need to be acquainted with market competition statue. it would ease the decision making and restructuring of market. The aim of this study is to measure the competition of the wholesale electricity market and then investigate the impact of market power on wholesale electricity price during 2013 to 2017. The Result shows that market share of P.U.s in the wholesale electricity marke...

Competition and Market-Entry Into the Swedish Pharmacy Market

Between the 1970s and 2009 the Swedish pharmacy market was characterized by a governmental monopoly with Apoteket AB as the only market-actor. By the year 2009, market reforms and re-regulations allowed private companies to enter the pharmacy market. Still, pertaining to existing regulations (e.g the pricing of prescription drugs) the market cannot be described as entirely free. The purpose of ...